Skip to main content
Premium Trial:

Request an Annual Quote

IonPath: Sander Gubbens

IonPath has appointed Sander Gubbens as CEO. He replaces company cofounder Harris Fienberg.

Gubbens was most recently president of Gatan, a cryo-electron microscopy firm, which was acquired by Amtek in 2019 for $925 million. He has over 30 years of experience in developing and commercializing technology in the life science, materials science, and semiconductor industries. Prior to Gatan, he held senior R&D roles at KLA-Tencor.

An inventor on 17 patents and a member of the board of PCR instrument maker Combinati, Gubbens holds a doctorate in applied physics from The Netherlands' Delft University of Technology and an MBA from the University of California, Berkeley Hass School of Business.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.